Revisions for Isavuconazole

Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

RevisionOperations
09-21-23 by ripal121current revision
09-21-23 by ripal121
07-20-23 by ripal121
07-20-23 by ripal121
02-17-22 by [email protected]
07-23-21 by conan.macdougal...
08-19-20 by [email protected]
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
07-10-20 by [email protected]
04-21-20 by ucsf_admin

Dosing: Adult Antimicrobial Dosing, Non-dialysis

Indication Dose Notes
All Indications 372 mg IV/PO Q8h x 6 doses (total of 48h), then 372 mg Q24h No renal dose adjustment

372mg of isavuconazonium=200mg of isavuconazole

Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis

Indication Dose Notes
All Indications 372 mg IV/PO Q8h x 6 doses (48h), then 372 mg IV/PO Q24h No dose adjustment in hemodialysis

372mg of isavuconazonium=200mg of isavuconazole

Dialysis Notes

Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min.  For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.

372mg of isavucazonium (prodrug) = 200mg of isavuconazole

Restricted to ID or Antimicrobial Stewardship except:​

1) Documented or suspected fungal pneumonia in a patient with prolonged QTc interval​

2) Prophylaxis against fungal infections in patients on the hematology/BMT service or lung transplant service with prolonged QTc interval or concurrent QTc prolonging medications.

References: